Skip to main content
Erschienen in: Brain Tumor Pathology 3/2018

09.05.2018 | Case Report

A case of epidural glioblastoma metastasis presenting with a cervical myelopathy, torticollis, and L’hermitte’s phenomenon

verfasst von: Michael W. Ruff, Adip G. Bhargav, Aditya Raghunathan

Erschienen in: Brain Tumor Pathology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Extraneural glioblastoma metastases are exceedingly rare, though previously described in the literature. Activating mutations in the BRAF kinase gene (V600E) are present in a minority of glioblastoma patients. Here, we describe a case of systemic metastases of a clonal subpopulation of BRAF V600E mutated glioblastoma in a patient previously treated with surgery, radiation, temozolomide and bevacizumab. The patient presented with a subacute cervical myelopathy during adjuvant treatment. He underwent emergent surgical decompression of an epidural spine metastasis. Analysis of the metastatic tumor demonstrated clonal expansion of a BRAF V600E subpopulation. Though rare, systemic metastasis of glioblastoma should be considered in patients presenting with subacute complaints in line with a mass lesion.
Literatur
1.
Zurück zum Zitat Blume C, von Lehe M, van Landeghem F, Greschus S, Bostrom J (2013) Extracranial glioblastoma with synchronous metastases in the lung, pulmonary lymph nodes, vertebrae, cervical muscles and epidural space in a young patient—case report and review of literature. BMC Res Notes 6:290CrossRefPubMedPubMedCentral Blume C, von Lehe M, van Landeghem F, Greschus S, Bostrom J (2013) Extracranial glioblastoma with synchronous metastases in the lung, pulmonary lymph nodes, vertebrae, cervical muscles and epidural space in a young patient—case report and review of literature. BMC Res Notes 6:290CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Ray A, Manjila S, Hdeib AM et al (2015) Extracranial metastasis of gliobastoma: three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol 3:479–486CrossRefPubMedPubMedCentral Ray A, Manjila S, Hdeib AM et al (2015) Extracranial metastasis of gliobastoma: three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol 3:479–486CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Anghileri E, Castiglione M, Nunziata R et al (2016) Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev 39:37–45 (discussion-6)CrossRefPubMed Anghileri E, Castiglione M, Nunziata R et al (2016) Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev 39:37–45 (discussion-6)CrossRefPubMed
4.
Zurück zum Zitat Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP (2016) Response of metastatic glioma to vemurafenib. Neuro-Oncology Practice 3:268–271CrossRef Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP (2016) Response of metastatic glioma to vemurafenib. Neuro-Oncology Practice 3:268–271CrossRef
6.
Zurück zum Zitat Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954CrossRefPubMed Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954CrossRefPubMed
8.
Zurück zum Zitat Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S (2016) Successful treatment of a progressive BRAF V600E-mutated anaplastic pleomorphic xanthoastrocytoma with vemurafenib monotherapy. J Clin Oncol 34:e87-9CrossRefPubMed Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S (2016) Successful treatment of a progressive BRAF V600E-mutated anaplastic pleomorphic xanthoastrocytoma with vemurafenib monotherapy. J Clin Oncol 34:e87-9CrossRefPubMed
9.
Zurück zum Zitat Behling F, Barrantes-Freer A, Skardelly M et al (2016) Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11:55CrossRefPubMedPubMedCentral Behling F, Barrantes-Freer A, Skardelly M et al (2016) Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11:55CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Funata N, Nobusawa S, Yamada R, Shinoura N (2016) A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation. Brain Tumor Pathol 33:57–62CrossRefPubMed Funata N, Nobusawa S, Yamada R, Shinoura N (2016) A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation. Brain Tumor Pathol 33:57–62CrossRefPubMed
11.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed
12.
14.
Zurück zum Zitat Fatt MA, Horton KM, Fishman EK (2008) Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient. J Comput Assist Tomogr 32:407–409CrossRefPubMed Fatt MA, Horton KM, Fishman EK (2008) Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient. J Comput Assist Tomogr 32:407–409CrossRefPubMed
15.
Zurück zum Zitat Buell JF, Trofe J, Sethuraman G et al (2003) Donors with central nervous system malignancies: are they truly safe? Transplantation 76:340–343CrossRefPubMed Buell JF, Trofe J, Sethuraman G et al (2003) Donors with central nervous system malignancies: are they truly safe? Transplantation 76:340–343CrossRefPubMed
16.
Zurück zum Zitat Dasgupta T, Olow AK, Yang X et al (2016) Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. J Neurooncol 126:385–393CrossRefPubMed Dasgupta T, Olow AK, Yang X et al (2016) Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. J Neurooncol 126:385–393CrossRefPubMed
18.
Zurück zum Zitat Xu H, Rahimpour S, Nesvick CL et al (2015) Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy. Oncotarget 6:11882–11893PubMedPubMedCentral Xu H, Rahimpour S, Nesvick CL et al (2015) Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy. Oncotarget 6:11882–11893PubMedPubMedCentral
19.
Zurück zum Zitat de Groot JF, Fuller G, Kumar AJ et al (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12:233–242CrossRefPubMedPubMedCentral de Groot JF, Fuller G, Kumar AJ et al (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12:233–242CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Fan F, Samuel S, Gaur P et al (2011) Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br J Cancer 104:1270–1277CrossRefPubMedPubMedCentral Fan F, Samuel S, Gaur P et al (2011) Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br J Cancer 104:1270–1277CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ayuso JM, Monge R, Martínez-González A et al (2017) Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncol 19:503–513PubMedPubMedCentral Ayuso JM, Monge R, Martínez-González A et al (2017) Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncol 19:503–513PubMedPubMedCentral
Metadaten
Titel
A case of epidural glioblastoma metastasis presenting with a cervical myelopathy, torticollis, and L’hermitte’s phenomenon
verfasst von
Michael W. Ruff
Adip G. Bhargav
Aditya Raghunathan
Publikationsdatum
09.05.2018
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 3/2018
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-018-0319-y

Weitere Artikel der Ausgabe 3/2018

Brain Tumor Pathology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.